{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:47:26Z","timestamp":1776235646071,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite significantly improved therapies in recent years, long-term morbidity and mortality in ANCA-associated vasculitis (AAV) remain high. The leading causes of death within the first year after diagnosis are active vasculitis and in subsequent years cardiovascular diseases, malignancies, and infections. Population-based database and cohort analyses suggest an increased risk for major adverse cardiovascular events (MACE) in AAV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed data samples from an electronic health records database of the US-based TriNetX network. Patients with the diagnostic codes granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) and patients without vasculitis as a matched control cohort (1:1) were included. To optimize between-group comparability, propensity score matching was performed for demographic variables and comorbidity. Hazard ratios (HR) for death and cardiovascular outcomes were calculated using univariate Cox regression after analyzing the matched cohort using the Kaplan-Meier method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 20, 422 patients with GPA and 5, 907 with MPA. Mortality was more frequent in patients with GPA (17.87%) and MPA (25.85%) than in matched controls (GPA controls: 5.79%; MPA controls: 9.70%), corresponding to an increased hazard of death in both cohorts (GPA: HR 3.01; MPA: HR 3.01). The risk of cardiovascular events was increased in GPA and MPA compared to matched controls, particularly for MACE (GPA: HR: 1.94, MPA: HR: 2.24) and thromboembolic events (deep vein thrombosis: GPA HR: 2.82, MPA HR: 3.33; pulmonary embolism: GPA HR: 3.01, MPA HR: 3.00) and did not differ when adjusted according to sex, disease duration, and age. Compared with GPA patients, MPA patients had a higher risk of MACE (HR: 1.13) and peripheral arterial disease (HR: 1.17).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AAV was associated with an increased risk of death and cardiovascular events. Compared with GPA, MPA was associated with an increased risk for MACE and peripheral arterial disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1794549","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:45:35Z","timestamp":1776231935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Sebastian","family":"Klapa","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]},{"name":"Institute of Experimental Medicine, Christian-Albrechts-University of Kiel c\/o German Naval Medical Institute","place":["Kronshagen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Vorobyev","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Independent Researcher","place":["Gro\u00df Gr\u00f6nau, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Vollert","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, Christian-Albrechts-University of Kiel c\/o German Naval Medical Institute","place":["Kronshagen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Olbrich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Nording","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site North","place":["L\u00fcbeck\/Kiel, Germany"]},{"name":"Department of Internal Medicine V, Angiology, Christian-Albrechts-University of Kiel","place":["Kiel, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]},{"name":"Azrieli Faculty of Medicine, Bar-Ilan University","place":["Safed, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Henrik","family":"Schirmer","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine I, Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel","place":["Kiel, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"von Allw\u00f6rden","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Staehle","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ludwig","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lamprecht","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-013-0869-6","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00025-0","article-title":"Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Arnold","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00035-3","article-title":"Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Falde","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac320","article-title":"Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis","volume":"38","author":"S\u00e1nchez \u00c1lamo","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00296-025-05883-7","article-title":"Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study","volume":"45","author":"Bekta\u015f","year":"2025","journal-title":"Rheumatol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100136","article-title":"Granulomatosis with polyangiitis and cardio vascular comorbidity in Denmark. A registry-based study of 21 years of follow-up","volume":"4","author":"Laustrup","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210677","article-title":"Long-term risk of heart failure and other adverse cardiovascular outcomes in granulomatosis with polyangiitis: a nationwide cohort study","volume":"49","author":"Sun","year":"2022","journal-title":"J Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac386","article-title":"Long-term cardiovascular outcomes and temporal trends in patients diagnosed with ANCA-associated vasculitis: a Danish nationwide registry study","volume":"62","author":"Nygaard","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab229","article-title":"Association of antineutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study","volume":"15","author":"Massicotte-Azarniouch","year":"2021","journal-title":"Clin Kidney J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105123","article-title":"Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study","volume":"103","author":"Olbrich","year":"2024","journal-title":"EBioMedicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.031","article-title":"Isotretinoin and the risk of psychiatric disturbances: a global study shedding new light on a debatable story","volume":"88","author":"Kridin","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae219","article-title":"Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids","volume":"191","author":"Kridin","year":"2024","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"St\u00fcrmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.ad","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06656-y","article-title":"Cardiovascular issues in rheumatic diseases","volume":"42","author":"Zimba","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead377","article-title":"Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study","volume":"63","author":"Nygaard","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105540","article-title":"Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: a prospective, two-centre cohort study","volume":"90","author":"Vegting","year":"2023","journal-title":"Joint Bone Spine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005055","article-title":"Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study","volume":"11","author":"Borgas","year":"2025","journal-title":"RMD Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac669","article-title":"High risk of stroke in ANCA-associated vasculitis-a population-based study","volume":"62","author":"Tabakovic","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61061074","article-title":"Clinical significance of peripheral arterial disease evaluation in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"61","author":"Whang","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4061-x","article-title":"Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case-control study","volume":"38","author":"Pacholczak","year":"2018","journal-title":"Rheumatol Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/s0140-6736(15)60345-2","article-title":"CD4+CD28- T-cell expansions in ANCA-associated vasculitis and association with arterial stiffness: baseline data from a randomised controlled trial","volume":"385","author":"Chanouzas","year":"2015","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588776","article-title":"T cells in autoimmunity-associated cardiovascular diseases","volume":"11","author":"Schwartz","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1794549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:45:37Z","timestamp":1776231937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1794549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2026.1794549"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1794549","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1794549"}}